You are here

Novartis

Conatus Pharma to explore options as liver disease drug fails trial

Yahoo/Reuters

Mon, 06/24/19 - 07:20 pm

Conatus Pharmaceuticals

clinical trials

Cost-effectiveness watchdogs skewer Novartis' MS drug Mayzent and J&J's depression spray Spravato

Fierce Pharma

Fri, 06/21/19 - 11:33 pm

3 Drugs Under FDA Review With Blockbuster Potential

Motley Fool

Fri, 06/21/19 - 11:24 am

rheumatoid arthritis

wet age-related macular degeneration

relapsing multiple sclerosis

Chutes & Ladders—Novartis says hello to new pharma chief

Fierce Biotech

Fri, 06/14/19 - 10:04 am

Marie-France Tschudin

The top 10 most-expensive meds in the U.S.—and they're not the usual suspects

Fierce Pharma

Thu, 06/13/19 - 12:14 pm

Spark Therapeutics

Novartis Close to Settling Kickback Violations, Filing Inadvertently Shows

BioSpace

Wed, 06/12/19 - 06:40 pm

physician gifts

Novartis’ Cosentyx achieves primary and secondary endpoints in psoriatic arthritis study

Pharmaceutical Business Review

Wed, 06/12/19 - 09:57 am

clinical trials

psoriatic arthritis

5 Most Valuable Pipeline Drugs in Development -- and the Stocks Poised to Profit

Motley Fool

Wed, 06/12/19 - 09:45 am

Vertex Pharmaceuticals

tezacaftor/ivacaftor

trastuzumab deruxtecan

The gene therapy era has arrived. So have the challenges.

Biopharma Dive

Sun, 06/9/19 - 01:43 pm

A struggling Sanofi is preparing to hire Novartis senior pharma exec Paul Hudson as new CEO, replacing Brandicourt -- report

Endpoints

Thu, 06/6/19 - 11:08 pm

Olivier Brandicourt

#ASCO19: MET inhibitors from Incyte/Novartis and Germany's Merck face off for rare subset of NSCLC patients

Endpoints

Tue, 06/4/19 - 12:16 pm

non-small cell lung cancer

Is $2.1 million too much for a drug? For affected parents, there is no debate

Stat

Mon, 06/3/19 - 11:28 am

Research Ayala's ex-BMS drug shows promise in triple-negative breast cancer

Fierce Biotech

Sun, 06/2/19 - 01:28 pm

Ayala Pharmaceuticals

triple negative breast cancer

ASCO 2019 day three

Pharmaforum

Sun, 06/2/19 - 01:09 pm

pancreatic cancer

ASCO 2019 day two

Pharmaforum

Sun, 06/2/19 - 01:01 pm

Gilead Sciences

ASCO: Novartis' Kisqali posts first-in-class survival win in younger women

Fierce Pharma

Sat, 06/1/19 - 12:45 pm

clinical trials

Why Concerns About a “Break Down” in Drug Pricing Are Misplaced

BIOTechNow

Sat, 06/1/19 - 12:40 pm

Is the $2.1 Million Price Tag for Novartis' Zolgensma Ridiculous?

Motley Fool

Fri, 05/31/19 - 11:53 pm

Novartis burnishes prospects for its big asthma drug with positive PhIII data from a similar treatment

Endpoints

Thu, 05/30/19 - 10:07 am

clinical trials

ASCO 2019 Preview: Presentations to Keep An Eye On

BioSpace

Thu, 05/30/19 - 09:35 am

OncoNano Medicine

Pages